A Canadian drug company is recalling birth control pills because they contain an extra week of placebo pills in place of the actual drug, health officials said. Apotex, maker of the Alysena-28 birth control pill, said it does not know how the packages were improperly filled. The recall includes nine different lots of the pill, the Canadian Broadcasting Corp. said Friday. Women can tell whether they have the correct dosage by whether their monthly package contains one row of white pills (the placebos) or two. Those with the extra row should be returned to the pharmacy. The extra week of placebos contain no health risk if taken but reduce the effectiveness of the birth control regimen. Canadian health officials expressed outrage at how Apotex handled the recall. At first the company only notified pharmacists and not doctors, professional societies or women themselves. \"I am concerned that Canadians may not have received important information in a timely manner. As a result, I have instructed Health Canada to look into the issue and assess whether processes were followed and that they are sufficient,\" Canadian Health Minister Leona Aglukkaq said.
GMT 14:01 2018 Thursday ,30 August
Expat with rare heart disorder gets life-saving surgeryGMT 00:18 2018 Tuesday ,23 January
Boy with 10-pound tumour on face diesGMT 21:23 2018 Monday ,22 January
All set for first global medical tourism conference in DubaiGMT 22:46 2018 Sunday ,21 January
Second face transplant for FrenchmanGMT 07:51 2018 Saturday ,20 January
Trio aquitted of negligence in Canada railway disasterGMT 10:57 2018 Thursday ,18 January
Breastfeeding for 6 months cuts diabetes risk in half: studyGMT 16:10 2018 Wednesday ,17 January
Child mummy in Italy had hepatitis, not smallpoxGMT 18:36 2018 Tuesday ,16 January
Greece strikes cause transport chaos, healthcare delays

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor